Dr. Christopher Wright appointed chief medical officer of Ring Therapeutics

Christopher Wright, MD, PhD, has been tapped as the first chief medical officer and head of translational research for Ring Therapeutics, a gene therapy company. He will assume his new role Feb. 7.

Advertisement

Dr. Wright joins Ring from AavantiBio, where he served as chief medical officer. He has also served as chief medical officer of Cyclerion Therapeutics and senior vice president and chief development officer of Ironwood Pharmaceuticals, according to a Jan. 30 news release from Ring Therapeutics.

Dr. Wright currently serves as a medical adviser to Cyclerion and on the board of directors for Alkermes.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Leadership

Advertisement

Comments are closed.